James Tibenderana

Joining the discussion is James Tibenderana, a doctor and the Global Technical Director at Malaria Consortium, who spearheads innovative strategies in malaria control. He explains the alarming rebound in malaria cases, despite advancements in prevention like vaccines and mosquito control. The talk delves into the unique transmission dynamics of malaria, the urgent need for community involvement, and the critical funding shortfall in combating the disease in sub-Saharan Africa. James emphasizes collaborative global efforts to shift from mere control to actual eradication.

In this insightful discussion, James Tibenderana, Chief Executive at the Malaria Consortium, shares vital advancements in malaria control for 2025, including breakthroughs in vaccine rollout and new treatment strategies. Abdoulaye Djimdé, Professor of Parasitology, details the clinical success of a new drug, Ganaplacide-lumefantrine, and its unique mechanism against resistance. Ellie Sherrard-Smith explains the innovative passive spatial emanators designed for indoor mosquito control, highlighting their role in reducing malaria transmission. The stakes are high amid funding cuts affecting global health initiatives.